Company:  ADMA BIOLOGICS, INC. (ADMA)
Form Type:  8-K
Filing Date:  8/10/2018 
CIK:  0001368514 
Address:  C/O ADMA BIOLOGICS, INC.
465 STATE ROUTE 17
 
City, State, Zip:  RAMSEY, New Jersey 07446 
Telephone:  (201) 478-5552 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$5.01  
Change: 
-0.02 (-0.40%)  
Trade Time: 
11:41 AM EST  
Market Cap: 
$232.22M
Trade ADMA now with 

© 2018  
Description of Business
Unless the context otherwise requires, references in this Business section to "ADMA," "ADMA Biologics," the "Company," "we," "us" and "our" refer to ADMA Biologics, Inc., a Delaware corporation, as well as its wholly- owned and indirectly owned subsidiaries, ADMA Plasma Biologics, Inc., a Delaware corporation, ADMA Bio Centers Georgia Inc., a Delaware corporation ("ADMA BioCenters") and ADMA BioManufacturing, LLC, a Delaware limited liability company ("ADMA BioManufacturing"). Overview We are a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company that manufactures, markets and develops specialty plasma-derived biologics for the treatment of immune deficiencies and prevention of certain infectious diseases. Our targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons.
Register and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02. Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURE
  EXHIBIT 99.1
    INCOME STATEMENT